Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing

L Guarini1, G M Graham, H Jiang

  • 1Division of Pediatric Hematology/Oncology, Columbia University, College of Physician & Surgeons, New York, NY 10032.

Pigment Cell Research
|January 1, 1992
PubMed

Insights

Melanoma treatment with mezerein (MEZ) and fibroblast interferon (IFN-beta) induces terminal differentiation and suppresses cell growth. This combination also increases melanin synthesis and alters cell surface antigen expression in melanoma cells.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Cancer cells often exhibit altered differentiation pathways.
  • Inducing terminal differentiation and growth arrest is a potential cancer treatment strategy.
  • Melanoma treatment research focuses on novel therapeutic approaches.

Purpose of the Study:

  • To investigate the effects of mezerein (MEZ) and fibroblast interferon (IFN-beta) on human melanoma cell differentiation and growth.
  • To analyze changes in gene and cell surface antigen expression during induced differentiation.
  • To determine if terminal differentiation is necessary for antigenic modulation.

Main Methods:

  • Treatment of HO-1 human melanoma cells with MEZ and IFN-beta.
  • Analysis of cell growth suppression, melanin synthesis, and cell surface antigen expression (ICAM-1, HLA Class I, HLA Class II).
  • Comparison with treatments using MEZ, IFN-beta, IFN-gamma, or combinations thereof.

Main Results:

  • MEZ plus IFN-beta combination rapidly and irreversibly suppressed HO-1 cell growth and increased melanin synthesis.
  • This combination also induced/increased expression of ICAM-1, HLA Class I, and HLA Class II antigens.
  • Neither IFN-beta nor MEZ alone produced the same extent of antigenic modulation.
  • Immune interferon (IFN-gamma) induced antigenic modulation but not differentiation or melanin synthesis.

Conclusions:

  • MEZ plus IFN-beta is a potent combination for inducing terminal differentiation and growth arrest in melanoma cells.
  • Antigenic modulation (ICAM-1, HLA Class I/II expression) occurs alongside differentiation but is not solely dependent on it.
  • IFN-gamma can modulate antigens independently of inducing terminal differentiation or melanin synthesis.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...